Array-CGH analysis was performed in 76 of the patients.  Our results suggest that array-CGH should be considered as a first line genetic test for children with cerebral malformations and refractory epilepsy unless there is a strong evidence for a specific monogenic syndrome.
Array-CGH
Array-CGH analysis was performed in 76 of the patients.  Our results suggest that array-CGH should be considered as a first line genetic test for children with cerebral malformations and refractory epilepsy unless there is a strong evidence for a specific monogenic syndrome.
Array-CGH
Array-CGH analysis was performed in 76 of the patients.  Our results suggest that array-CGH should be considered as a first line genetic test for children with cerebral malformations and refractory epilepsy unless there is a strong evidence for a specific monogenic syndrome.
Array-CGH